CIC mutations have subsequently been associated with advanced stage lung adenocarcinomas [45], metastatic progression of prostate cancer [46], gastric adenocarcinoma [45], and hepatocellular carcinoma [47]. This evidence concerns the gene CIC and hepatocellular carcinoma.